Literature DB >> 7689405

Involvement of nitric oxide synthase in the delayed vasodilator response to ultraviolet light irradiation of rat skin in vivo.

J B Warren1, R K Loi, M L Coughlan.   

Abstract

1. The role of nitric oxide synthase and cyclo-oxygenase in the skin blood flow response to ultraviolet light B (u.v.B) irradiation was investigated in the rat in vivo. 2. Local skin blood flow changes were measured in the shaved dorsal skin of anaesthetized male Sprague-Dawley rats with a laser Doppler flow probe. 3. u.v.B irradiation caused delayed onset vasodilation and by 18 h basal blood flow increased by 125 +/- 25% (P < 0.05, n = 12 rats, mean +/- s.e. mean). 4. Indomethacin, 3 nmol per site, NG-nitro-L-arginine methyl ester (L-NAME) 100 nmol per site, but not D-NAME 100 nmol per site, injected locally 17.5 h after u.v.B irradiation abolished the 18 h increase in blood flow. 5. The nitric oxide synthase inhibitor L-NAME, NG-monomethyl-L-arginine (L-NMMA) and canavanine, 10 and 100 nmol per site injected at 17.5 h, suppressed significantly the u.v.B 18 h response in a dose-dependent manner. The order of potency was L-NAME > canavanine = L-NMMA. The effect of L-NAME was reversed partially by the co-injection of an excess of L-arginine. 6. Topical application of the corticosteroid, clobetasol 17-propionate, immediately after irradiation inhibited the 18 h u.v.B response in a dose-dependent manner. 7. The delayed onset microcirculatory vasodilation induced by u.v.B involves both nitric oxide synthase and cyclo-oxygenase in this in vivo model. Topical corticosteroids may attenuate the response by inhibiting both prostaglandin and nitric oxide synthesis pathways.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689405      PMCID: PMC2175655          DOI: 10.1111/j.1476-5381.1993.tb13645.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation.

Authors:  R J Flower; G J Blackwell
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

2.  Microcirculatory responses to prostacyclin and PGE2 in the rat cremaster muscle.

Authors:  E J Messina; G Kaley
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1980

3.  Role of prostaglandin-mediated vasodilatation in inflammation.

Authors:  T J Williams; M J Peck
Journal:  Nature       Date:  1977-12-08       Impact factor: 49.962

4.  Local increase in interleukin-1-like activity following UVB irradiation of human skin in vivo.

Authors:  G M Murphy; P M Dowd; B N Hudspith; J Brostoff; M W Greaves
Journal:  Photodermatol       Date:  1989-12

5.  Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion.

Authors:  T B McCall; N K Boughton-Smith; R M Palmer; B J Whittle; S Moncada
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

6.  Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin.

Authors:  T J Williams
Journal:  Br J Pharmacol       Date:  1982-11       Impact factor: 8.739

7.  Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation.

Authors:  T J Williams
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

8.  Endotoxin-induced vasodilatation in anaesthetized rat skin involves nitric oxide and prostaglandin synthesis.

Authors:  J B Warren; M L Coughlan; T J Williams
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

9.  Inhibition of bradykinin vasodilation and potentiation of norepinephrine and angiotensin vasoconstriction by inhibitors of prostaglandin synthesis in skeletal muscle of the rat.

Authors:  E J Messina; R Weiner; G Kaley
Journal:  Circ Res       Date:  1975-10       Impact factor: 17.367

10.  Inhibition of prostacyclin production mediates permissive effect of glucocorticoids on vascular tone. Perturbations of this mechanism contribute to pathogenesis of Cushing's syndrome and Addison's disease.

Authors:  L Axelrod
Journal:  Lancet       Date:  1983-04-23       Impact factor: 79.321

View more
  6 in total

Review 1.  Inducible nitric oxide synthase in inflammation.

Authors:  V Cattell; A Jansen
Journal:  Histochem J       Date:  1995-10

2.  Increase of particulate nitric oxide synthase activity and peroxynitrite synthesis in UVB-irradiated keratinocyte membranes.

Authors:  G Deliconstantinos; V Villiotou; J C Stavrides
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

Review 3.  Regulatory Role of Nitric Oxide in Cutaneous Inflammation.

Authors:  Mao-Qiang Man; Joan S Wakefield; Theodora M Mauro; Peter M Elias
Journal:  Inflammation       Date:  2022-01-30       Impact factor: 4.092

4.  Adenylate cyclase-mediated vascular responses of rabbit aorta, mesenteric artery and skin microcirculation.

Authors:  A J Wilson; J B Warren
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

5.  Release by ultraviolet B (u.v.B) radiation of nitric oxide (NO) from human keratinocytes: a potential role for nitric oxide in erythema production.

Authors:  G Deliconstantinos; V Villiotou; J C Stravrides
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

6.  In vivo experimental evidence that the nitric oxide pathway is involved in the X-ray-induced antiangiogenicity.

Authors:  O Hatjikondi; P Ravazoula; D Kardamakis; J Dimopoulos; S Papaioannou
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.